Beate Kiese
Novartis (Switzerland) · 15 works · 7,436 citations · h-index 10
Top works
- Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal Tumors
- Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor
- Translocator Protein (18 kD) as Target for Anxiolytics Without Benzodiazepine-Like Side Effects
- Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor
- Pharmacokinetics of a Rivastigmine Transdermal Patch Formulation in Healthy Volunteers: Relative Effects of Body Site Application
- Efficacy of anti-sclerostin monoclonal antibody BPS804 in adult patients with hypophosphatasia
- Pharmacokinetics and Bioavailability of the Novel Rivastigmine Transdermal Patch Versus Rivastigmine Oral Solution in Healthy Elderly Subjects
- Cannabinoid Receptor Agonist 13, a Novel Cannabinoid Agonist: First in Human Pharmacokinetics and Safety
- The single dose pharmacokinetic profile of a novel oral human parathyroid hormone formulation in healthy postmenopausal women
- Phase III efficacy study of interleukin‐3 after autologous bone marrow transplantation in patients with malignant lymphoma
- Randomized trial of recombinant human interleukin-3 versus placebo in prevention of bone marrow depression during first-line chemotherapy for ovarian carcinoma.
- Kinase M utations a nd I matinib R esponse i n P atients W ith Metastatic G astrointestinal S tromal T umor